---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-106933"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2024-12-09T23:59:59+00:00"
generated_at: "2026-05-29T05:58:06.005319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ImmuCell VP of Manufacturing to retire July 2025; enters separation agreement

## Summary
- Elizabeth L. Williams moves to part-time effective Dec 7, 2024; retires July 1, 2025.
- She will work ≤10 hrs/week transitioning tasks; all prior employment agreements terminated.
- Eligible for $100,000 transition incentive if she works through June 30, 2025 and signs affirmation.
- Outstanding stock options continue to vest per plan terms until separation date.
- During transition she accrues no PTO and loses group health coverage (COBRA available at own cost).

## SEC filing metadata
- accession: 0001213900-24-106933
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2024-12-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000121390024106933/0001213900-24-106933-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000121390024106933/ea0224119-8k_immucell.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-106933
- JSON: https://secwatch.observer/filing/0001213900-24-106933.json
- Plain text: https://secwatch.observer/filing/0001213900-24-106933.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.